Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
India
· Delayed Price · Currency is INR 106.14
-0.85 (-0.79%)
Mar 10, 2026, 10:37 AM IST
Bafna Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 41.53 | 73.48 | 113.38 | 52.16 | 58.27 | Upgrade
|
| Depreciation & Amortization | - | 48.9 | 49.95 | 53.34 | 54.93 | 44.78 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.74 | -0.66 | -1.96 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | -2.83 | 6 | 6.73 | - | - | Upgrade
|
| Other Operating Activities | - | 57.53 | 18.87 | 22.24 | -1.86 | -6.61 | Upgrade
|
| Change in Accounts Receivable | - | 55.04 | -48.46 | -270.42 | -61.12 | -35.25 | Upgrade
|
| Change in Inventory | - | 11.8 | -74.23 | -19.39 | -48.37 | -40.31 | Upgrade
|
| Change in Accounts Payable | - | -44.77 | 69.62 | 160.56 | 122.18 | -18.5 | Upgrade
|
| Change in Other Net Operating Assets | - | 53.42 | 0.28 | -14.95 | -20.64 | -138.48 | Upgrade
|
| Operating Cash Flow | - | 221.36 | 94.85 | 49.53 | 97.28 | -136.09 | Upgrade
|
| Operating Cash Flow Growth | - | 133.38% | 91.52% | -49.09% | - | - | Upgrade
|
| Capital Expenditures | - | -218.6 | -155.78 | -67.19 | -75.41 | -60.95 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.59 | 1.71 | 1.96 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -2.7 | -15 | - | - | Upgrade
|
| Investment in Securities | - | -0.01 | - | - | - | - | Upgrade
|
| Other Investing Activities | - | 6.39 | 6.24 | 5.29 | 9.97 | 7.49 | Upgrade
|
| Investing Cash Flow | - | -211.63 | -150.54 | -74.93 | -65.44 | -53.45 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 98.68 | Upgrade
|
| Long-Term Debt Issued | - | 38.09 | 14.65 | 118.65 | - | 25 | Upgrade
|
| Total Debt Issued | - | 38.09 | 14.65 | 118.65 | - | 123.68 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -47.27 | - | Upgrade
|
| Total Debt Repaid | - | - | - | - | -47.27 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | 38.09 | 14.65 | 118.65 | -47.27 | 123.68 | Upgrade
|
| Other Financing Activities | - | -27.46 | -23.11 | -16.87 | -0.88 | -0.89 | Upgrade
|
| Financing Cash Flow | - | 10.64 | -8.45 | 101.77 | -48.15 | 122.8 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -0.02 | Upgrade
|
| Net Cash Flow | - | 20.37 | -64.14 | 76.36 | -16.31 | -66.76 | Upgrade
|
| Free Cash Flow | - | 2.76 | -60.93 | -17.66 | 21.87 | -197.04 | Upgrade
|
| Free Cash Flow Margin | - | 0.19% | -4.00% | -1.53% | 2.57% | -27.67% | Upgrade
|
| Free Cash Flow Per Share | - | 0.12 | -2.58 | -0.75 | 0.93 | -8.32 | Upgrade
|
| Cash Interest Paid | - | 27.46 | 23.11 | 16.87 | 0.88 | 0.89 | Upgrade
|
| Cash Income Tax Paid | - | -3.5 | 1.74 | 1.28 | 1.7 | - | Upgrade
|
| Levered Free Cash Flow | - | -74.58 | -124.36 | -97.3 | 13.94 | -215.85 | Upgrade
|
| Unlevered Free Cash Flow | - | -58.57 | -112.25 | -86.07 | 17.22 | -215.29 | Upgrade
|
| Change in Working Capital | - | 75.49 | -52.8 | -144.2 | -7.95 | -232.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.